Dose optimization is a necessary method to ensure patients receive the appropriate amount of medicine and an important consideration as part of a long development process. By leveraging Model-Informed Drug Development (MIDD), dose optimization creates a path to keeping oncology clinical trials on pace from an early stage.
MIDD In Early Oncology Clinical Development : Dose Optimization & Beyond
